Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

One of the main challenges when it comes to effective diagnosis and treatment for ovarian cancer is the complexity of identifying symptoms. This is largely due to the fact that most ovarian cancer ...

Ovarian cancer, often termed a 'silent killer,' is frequently diagnosed late due to subtle, easily dismissed early symptoms ...

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope ...

While a common misconception about endometriosis is that it is simply a "menstruation disease," EndoFound says it's in fact a ...

UTEP researchers identify Claudin-4 protein as a target to improve immune response against aggressive ovarian cancer.

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

The moment that we were told that they were raising this money, my wife and I got on our knees in our bedroom and we prayed,” ...

First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...

FZOCUS-1 assessed the safety and efficacy of fuzuloparib alone and in combination with apatinib for patients with newly diagnosed or advanced ovarian cancer.